Up to $100 million in additional loan proceeds provide additional financial flexibility to advance detalimogene development and commercialization for bladder cancer$25 million advanced at close of the ...
Stockhead on MSN
Health check: Ticker device giant backs Anteris Technologies’ hearty $430m-plus raise
Anteris Technologies plans a US$200 million public raising and US$90 million placement to fund development of its artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback